Position in JNJ
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$23,909,497
-$276,863 QoQ
Shares Held
94,143
-4.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#671
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2021CallValue
$34,214
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. JNJ ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in JNJ
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,909,497 | 94,143 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $24,186,360 | 98,946 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $22,111,986 | 106,847 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $22,132,472 | 119,364 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $14,646,433 | 95,885 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $12,599,859 | 75,976 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $20,588,825 | 142,365 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $24,674,607 | 152,256 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,478,211 | 146,950 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $21,821,044 | 137,942 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $21,376,671 | 136,383 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $16,260,455 | 104,401 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $18,280,690 | 110,444 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $16,959,790 | 109,418 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,476,914 | 115,918 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,711,360 | 132,905 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $21,882,899 | 123,277 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $18,709,639 | 105,567 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $17,746,972 | 103,741 | Shares | Sole | 2022-02-17 | |
| 2021-12-31 | $34,214 | 200 | Call | Sole | 2022-02-17 | |
| 2021-09-30 | $32,300 | 200 | Call | Sole | 2021-12-03 | |
| 2021-09-30 | $2,000 | 1,000 | Put | Sole | 2021-12-03 | |
| 2021-09-30 | $16,509,983 | 102,229 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $15,819,487 | 96,027 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $15,201,553 | 92,495 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $14,036,879 | 89,191 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,697,528 | 85,287 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $11,951,018 | 84,982 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,000 | 800 | Call | Sole | 2020-05-11 | |
| 2020-03-31 | $10,596,615 | 80,810 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||